Akito Fukuda

Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated EGFR-mutated advanced non-small cell lung cancer: a prospective observational study

S. Yano, K. Takayama, J. Uchino, 2021, Translational lung cancer research.

Unusual manifestation of disseminated herpes simplex virus type 2 infection associated with pharyngotonsilitis, esophagitis, and hemophagocytic lymphohisitocytosis without genital involvement

T. Hishima, H. Hasegawa, H. Katano, 2019, BMC Infectious Diseases.

An analysis of the radiological factors associated with respiratory failure in COVID-19 pneumonia and the CT features among different age categories

A. Imamura, Taiichiro Kobayashi, S. Fujiwara, 2021, Japanese Journal of Radiology.

How many coinfected patients with influenza and COVID-19 are there in a single Japanese hospital during the first wave?

Y. Hosomi, A. Imamura, Taiichiro Kobayashi, 2021, Japanese journal of infectious diseases (Print).

Cisplatin and Irinotecan as First-Line Chemotherapy for Previously Untreated Metastatic Thymic Carcinoma: Updated Analysis

Y. Hosomi, T. Hishima, Y. Okuma, 2022, Frontiers in Oncology.

High levels of AXL expression in untreated EGFR ‐mutated non‐small cell lung cancer negatively impacts the use of osimertinib

T. Mitsudomi, S. Yano, K. Takayama, 2022, Cancer science.

Treatment of advanced ALK-rearranged NSCLC following second-generation ALK–TKI failure

Akito Fukuda, T. Yoshida, 2023, Expert review of anticancer therapy.

Efficacy and safety of chemoimmunotherapy in advanced non-small cell lung cancer patients with antibiotics-induced dysbiosis: a propensity-matched real-world analysis

S. Nomura, H. Horinouchi, Y. Shinno, 2024, Journal of cancer research and clinical oncology.